Objective Use of the frailty index to measure an accumulation of deficits has been proven a
valuable method for identifying elderly people at risk for increased vulnerability, disease …

Background X-linked hypophosphatemia (XLH) is an inherited disease of phosphate
metabolism in which inactivating mutations of the Phosphate Regulating Endopeptidase …

Fibroblast growth factor 23 (FGF23) is produced by bone cells and regulates renal
phosphate and vitamin D metabolism, as well as causing left ventricular hypertrophy. FGF23 …

The innate immune system is the first line of host defense, and it is capable of resisting both
exogenous pathogenic challenges and endogenous danger signals via different pattern …

Abstract Fibroblast growth factor 23 (FGF23) is an important bone hormone that regulates
phosphate homeostasis in the kidney along with active vitamin D (1, 25 (OH) 2D3) and …

Osteocytes, which represent up to 95% of adult skeletal cells, are deeply embedded in bone.
These cells exhibit important interactive abilities with other bone cells such as osteoblasts …

Fibroblast growth factor 23 (FGF 23) is mainly produced in the bone and, upon secretion,
forms a complex with a FGF receptor and coreceptor αKlotho. FGF 23 can exert several …

Abstract Fibroblast growth factor 23 (FGF23) is a major endocrine regulator of phosphate
and 1, 25 (OH) 2 vitamin D 3 metabolism and is mainly produced by osteocytes. Its …

Abstract Fibroblast growth factor 23 (FGF23) is released primarily from
osteoblasts/osteocytes in bone. In cooperation with the transmembrane protein Klotho …

The fibroblast growth factor (FGF23) plasma level is high in cardiac and renal failure and is
associated with poor clinical prognosis of these disorders. Both diseases are paralleled by …